These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 29488016)
1. An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature. Sundaram SM; Chung L Curr Rheumatol Rep; 2018 Feb; 20(2):10. PubMed ID: 29488016 [TBL] [Abstract][Full Text] [Related]
3. Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH). Sobanski V; Launay D; Hachulla E; Humbert M Curr Rheumatol Rep; 2016 Feb; 18(2):10. PubMed ID: 26841964 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data. Thoreau B; Mouthon L Autoimmun Rev; 2024 Apr; 23(4):103506. PubMed ID: 38135175 [TBL] [Abstract][Full Text] [Related]
5. Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension. Thakkar V; Nikpour M; Stevens WM; Proudman SM Intern Med J; 2015 Mar; 45(3):248-54. PubMed ID: 25735576 [TBL] [Abstract][Full Text] [Related]
6. Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes. Brown Z; Proudman S; Morrisroe K; Stevens W; Hansen D; Nikpour M Semin Arthritis Rheum; 2021 Jun; 51(3):495-512. PubMed ID: 33857705 [TBL] [Abstract][Full Text] [Related]
9. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes. Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review. Bazan IS; Mensah KA; Rudkovskaia AA; Adonteng-Boateng PK; Herzog EL; Buckley L; Fares WH Respir Med; 2018 Jan; 134():42-46. PubMed ID: 29413506 [TBL] [Abstract][Full Text] [Related]
11. Performance of screening algorithms in systemic sclerosis-related pulmonary arterial hypertension: a systematic review. Thakkar V; Stevens WM; Moore OA; Nikpour M Intern Med J; 2013 Jul; 43(7):751-60. PubMed ID: 23611651 [TBL] [Abstract][Full Text] [Related]
12. Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis. Valenzuela A; Nandagopal S; Steen VD; Chung L Rheum Dis Clin North Am; 2015 Aug; 41(3):489-506. PubMed ID: 26210131 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment. Cansu DÜ; Korkmaz C Clin Rheumatol; 2023 Oct; 42(10):2601-2610. PubMed ID: 36396789 [TBL] [Abstract][Full Text] [Related]
14. Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening. Denton CP; Hachulla E Eur Respir Rev; 2011 Dec; 20(122):270-6. PubMed ID: 22130820 [TBL] [Abstract][Full Text] [Related]
15. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Condliffe R; Kiely DG; Peacock AJ; Corris PA; Gibbs JS; Vrapi F; Das C; Elliot CA; Johnson M; DeSoyza J; Torpy C; Goldsmith K; Hodgkins D; Hughes RJ; Pepke-Zaba J; Coghlan JG Am J Respir Crit Care Med; 2009 Jan; 179(2):151-7. PubMed ID: 18931333 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme. Morrisroe K; Stevens W; Sahhar J; Rabusa C; Nikpour M; Proudman S; Arthritis Res Ther; 2017 Mar; 19(1):42. PubMed ID: 28270192 [TBL] [Abstract][Full Text] [Related]